ADVISORY: PARTICIPATION OF SOUTH AFRICA IN THE COVID-19 VACCINES GLOBAL ACCESS (COVAX) FACILITY 2021-07-26T13:41:51+02:00Sep 17th, 2020|MAC Advisories| 1 – Advisory_MAC_Vacc_Covax_17Sep2020VPF2 1 – Annexure B_Priority groups 1 – Appendix 1 – COVAX Costing facebooktwitterlinkedinwhatsappEmail Related Posts Background document supporting the recommendations for selective vaccination of children 12-17 years old with COVID-19 vaccines in South Africa. BACKGROUND DOCUMENT MANDATORY COVID-19 VACCINATIONS IN CERTAIN WORKPLACES MAC Advisory: MITIGATING THE IMPACT OF COVID-19 DURING THE MUNICIPAL ELECTIONS – UPDATE ADVISORY ON BOOSTER JOHNSON & JOHNSON VACCINE FOR HEALTHCARE WORKERS – V2
